Search Press releases Keywords From To 19 Mar 2025 New data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular Dystrophy Association (MDA) 2025 Conference Read More 14 Mar 2025 Acquisition of own shares Read More 12 Mar 2025 Transparency notification BlackRock, Inc. Read More 11 Mar 2025 Transparency notification BlackRock, Inc. Read More 7 Mar 2025 Share Repurchase Program 2025 to cover UCB's Long Term Incentive Plans for employees Read More 7 Mar 2025 BIMZELX[®] (bimekizumab-bkzx) five-year data at AAD 2025 showed sustained skin clearance and long-term efficacy in moderate-to-severe plaque psoriasis Read More Pagination First page Previous page Previous … Page 11 Page 12 Page 13 Page 14 Current page 15 Page 16 Page 17 Page 18 Page 19 … Page 15 of 67 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe